Vicarious Surgical (RBOT) Competitors

Inogen (NASDAQ:INGN) and Vicarious Surgical (NYSE:RBOT) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, media sentiment, valuation, analyst recommendations, risk, institutional ownership and community ranking.

Which has higher earnings & valuation, INGN or RBOT?

Vicarious Surgical has lower revenue, but higher earnings than Inogen. Inogen is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inogen	$315.66M	0.75	-$102.45M	-$2.25	-4.40
Vicarious Surgical	N/A	N/A	-$71.07M	-$10.29	-1.40

Do analysts rate INGN or RBOT?

Inogen presently has a consensus target price of $7.00, indicating a potential downside of 29.36%. Vicarious Surgical has a consensus target price of $10.25, indicating a potential downside of 28.72%. Given Vicarious Surgical's higher possible upside, analysts plainly believe Vicarious Surgical is more favorable than Inogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inogen	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Vicarious Surgical	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Which has more risk & volatility, INGN or RBOT?

Inogen has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500. Comparatively, Vicarious Surgical has a beta of 1.32, meaning that its stock price is 32% more volatile than the S&P 500.

Does the MarketBeat Community favor INGN or RBOT?

Inogen received 381 more outperform votes than Vicarious Surgical when rated by MarketBeat users. Likewise, 69.22% of users gave Inogen an outperform vote while only 33.33% of users gave Vicarious Surgical an outperform vote.

Company	Underperform	Outperform
Inogen	Outperform Votes 389 69.22%	Underperform Votes 173 30.78%
Vicarious Surgical	Outperform Votes 8 33.33%	Underperform Votes 16 66.67%

Do insiders & institutionals have more ownership in INGN or RBOT?

89.9% of Inogen shares are owned by institutional investors. Comparatively, 47.3% of Vicarious Surgical shares are owned by institutional investors. 1.0% of Inogen shares are owned by company insiders. Comparatively, 11.7% of Vicarious Surgical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Is INGN or RBOT more profitable?

Vicarious Surgical has a net margin of 0.00% compared to Inogen's net margin of -15.89%. Inogen's return on equity of -27.38% beat Vicarious Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inogen	-15.89%	-27.38%	-16.77%
Vicarious Surgical	N/A	-81.46%	-63.62%

Does the media refer more to INGN or RBOT?

In the previous week, Vicarious Surgical had 3 more articles in the media than Inogen. MarketBeat recorded 5 mentions for Vicarious Surgical and 2 mentions for Inogen. Inogen's average media sentiment score of 0.89 beat Vicarious Surgical's score of 0.55 indicating that Inogen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inogen	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Vicarious Surgical	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Inogen beats Vicarious Surgical on 8 of the 15 factors compared between the two stocks.